You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
26 April 2022
APEIRON shareholders approve new group structure geared towards enabling innovation and growth
12 October 2021
APEIRON Biologics commences clinical COVID-19 trial with inhaled APN01
6 July 2021
APEIRON Biologics launches next clinical trial with innovative cancer therapy APN401
1 June 2021
APEIRON Biologics Announces Changes to Management and Supervisory Boards
19 May 2021
APEIRON Biologics’ APN01 selected for large-scale US trial in COVID-19
12 March 2021
APEIRON’s APN01 shows clinical benefits for severely ill COVID-19 patients in phase 2 trial